Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05143840
Title Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Augusta University
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.